Use of charcoal haemoperfusion in 55 acute poisonings.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Mydlík.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The changes of middle molecular substances (MMS) in a group of 13 patients with acute renal failure of various origin were determined by gel filtration on Sephadex G 15. The concentrations of plasma middle molecular substances increased rapidly during the oliguric phase and decreased during the diuretic phase of acute renal failure. However, it was significantly higher than in the controls. The concentration of MMS in the convalescent phase was still increased. In the oliguric phase of acute renal failure, before and 4 hours after haemodialysis a direct dependence was found between fraction 5 and serum urea. In the oliguric phase, this occurred between fraction 6 and serum urea. In the diuretic phase a direct dependence was demonstrated between fraction 4 and serum urea, as well as serum creatinine. It was found that MMS are contributing to the development of uraemic syndrome in acute renal failure.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Platelet count did not significantly decrease after charcoal haemoperfusion in patients with acute poisoning and significantly decreased during regular dialysis treatment. Adherent platelets and leucocytes were found on the surface of granules after haemoperfusion using a scanning electron microscope. Decreased platelet count returned to the original level at 48 to 72 hours after charcoal haemoperfusion.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.